•
Jun 30, 2024

Solid Biosciences Q2 2024 Earnings Report

EPS
-$0.61
Previous year: -$1.25
-51.2%
Gross Profit
-$1.24M
Cash and Equivalents
$190M
Previous year: $91.6M
+107.8%
Free Cash Flow
-$21.8M
Previous year: -$28M
-22.3%
Total Assets
$231M
Previous year: $205M
+12.8%

Solid Biosciences

Solid Biosciences